Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area mapk jnk'

Search results for: 'research area mapk jnk'

Items 31-40 of 72

Page
per page
  1. RAF265
    A8313 RAF265
    Target: Raf|VEGFR
    Summary: Multiple intracellular kinases inhibitor
      ≥25.9 mg/mL
  2. Sorafenib Tosylate
    A8245 Sorafenib Tosylate
     1 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥31.85 mg/mL
  3. Sorafenib
    A3009 Sorafenib
     2 Citation
    Target: Raf|VEGFR
    Summary: Raf kinases and tyrosine kinases inhibitor
      ≥23.25 mg/mL
  4. CEP 1347
    B7720 CEP 1347
    Summary: JNK inhibitor
      <6.16 mg/mL
  5. VX-702
    A8687 VX-702
    Summary: P38α MAPK inhibitor,highly selective and ATP-competitive
      insoluble in H2O; ≥20.2 mg/mL
  6. Losmapimod
    B4620 Losmapimod
     1 Citation
    Summary: p38 MAPK inhibitor, orally active
      insoluble in EtOH; insoluble in H2O; ≥19.15 mg/mL
  7. BI 78D3
    B9011 BI 78D3
    Summary: Competitive JNK inhibitor
      Soluble in DMSO
  8. AEG 3482
    B9010 AEG 3482
    Target: JNK
    Summary: inhibitor of Jun kinase (JNK)-dependent apoptosis
      insoluble in EtOH; insoluble in H2O; ≥14 mg/mL
  9. Anisomycin
    B6674 Anisomycin
    Target: p38|JNK|SAPK
    Summary: JNK agonist, potent and specific
      ≥26.5 mg/mL
  10. PD 169316
    A8689 PD 169316
    Target: p38
    Summary: P38 MAPK inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.3 mg/mL

Items 31-40 of 72

Page
per page